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Can continuous positive airway pressure  
therapy have antiarrhythmic properties?
Czy CPAP może mieć działanie antyarytmiczne?
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1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland
A 61-year-old obese (body mass index 36.6 kg/m2) male with diabetes mellitus was admitted to the hospital due to an 
exacerbation of chronic heart failure. He had poorly controlled arterial hypertension complicated by heart muscle hyper-
trophy and grade III retinopathy. Arterial hypertension was treated with renal denervation in the past, but the procedure 
did not result in any significant improvement in blood pressure (BP) control (prior to the hospitalisation the patient was 
receiving four hypotensive agents, including diuretic). On admission his office BP values were 170/85 mm Hg. The patient 
had his BP pharmacologically lowered, and was scheduled to have 24-h electrocardiography (ECG) Holter monitoring. 
ECG monitoring showed sinus rhythm with a mean heart rate of 56 bpm, and numerous ventricular extrasystoles. Also 
975 sinus pauses lasting less than 2.55 s were recorded. The histograms depicted in Figure 1A show an association between 
the number of pauses per hour and the time of day. Interestingly, the pauses and most of the episodes of bradycardia were 
recorded in the nighttime. Few sinus pauses were also recorded during the patient’s nap in the late evening. Because of 
obesity and daytime sleepiness the patient was scheduled to have a whole-night polygraph examination (Embletta® MPR 
PG, Ontario, Canada), along with same-time ECG monitoring. The study revealed severe obstructive sleep apnoea (OSA) 
with an apnoea-hypopnea index of 48.3 per hour. The 
apnoea episodes were in close time-association with 
the bradycardia episodes, and pauses were directly 
induced by apnoea episodes. Figure 1B depicts a frag-
ment of the polygraph study with visible, repetitive 
apnoea episodes associated with desaturation. The 
patient received treatment with continuous positive 
airway pressure (auto CPAP, ResMed S9 EscapeTM). He 
tolerated the treatment well. The patient had good 
compliance — he used the CPAP for at least 5.5 h every 
night. After 7 and 30 nights of treatment, extended 
72-h ECG monitoring was performed. This time the 
study showed no episodes of bradycardia with heart 
rate lower than 52 bpm. The number of pauses was 
reduced by over 90%. Modification of hypertension 
pharmacotherapy along with CPAP use resulted also in 
significant lowering of the BP values, and ambulatory 
BP monitoring revealed normalisation of nocturnal 
values, with preserved dipping profile (Fig. 2). Six 
months after the hospitalisation the patient is doing 
well, he is tolerating the CPAP treatment perfectly, 
has good BP control, and has not suffered any heart 
failure exacerbations. The present case highlights the 
importance of OSA in the pathogenesis of cardiac ar-
rhythmias and resistant hypertension. OSA is associated 
with repetitive episodes of hypoxaemia, desaturation, 
and microarousals, which, along with changes in the 
transthoracic pressure, promotes autonomic dysregula-
tion and cardiac arrhythmias. 
Figure 2. Results of ambulatory blood pressure monitoring after 
continuous positive airway pressure treatment
Figure 1. Daytime and nighttime distribution of electrocardio gram-
-proven sinus pauses (A), and potentially responsible, obstructive 
sleep apnoea episodes recorded in the polygraph study (B)
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